VAXNEUVANCE 2 ug/.5mL

VAXNEUVANCE 2 ug/0.5mL is a pneumococcal 15-valent conjugate vaccine designed for intramuscular administration. It helps protect against pneumococcal diseases caused by 15 serotypes. This vaccine is suitable for individuals at risk of pneumococcal infections.

VAXNEUVANCE is a pneumococcal 15-valent conjugate vaccine used to prevent infections caused by 15 serotypes of Streptococcus pneumoniae. It is commonly administered to individuals who are at higher risk of pneumococcal diseases, such as those with weakened immune systems or certain medical conditions. The vaccine works by stimulating the body's immune response to develop protection against these serotypes.

Common effects of VAXNEUVANCE may include mild to moderate reactions at the injection site, such as redness, swelling, or pain. Some individuals may also experience general symptoms like fatigue, headache, or muscle aches. These effects are typically temporary and resolve on their own within a few days.

VAXNEUVANCE should be administered by healthcare professionals trained in vaccination procedures. It is important to inform your healthcare provider about any allergies or medical conditions before receiving the vaccine. Individuals with severe allergies to any component of the vaccine should avoid its use.

VAXNEUVANCE may interact with other medications or vaccines. It is advisable to discuss your current medications and vaccination history with your healthcare provider before receiving this vaccine. Avoid taking alcohol or other immune-suppressing substances around the time of vaccination.